ECCO2R
ECCO2R is a medical device with 7 clinical trials. Historical success rate of 50.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
40.0%
2 of 5 finished
60.0%
3 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
CO2 Removal in Severe Acute exacerbatIons of Chronic Obstructive Lung Diseases
Extracorporeal CO2 Removal for Acute Decompensation of COPD
Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome
ECCO2R as an Adjunct to NIV in AECOPD
ECCO2R in the Treatment of Acute Exacerbation of COPD With Severe Hypercapnia
Clinical Trials (7)
CO2 Removal in Severe Acute exacerbatIons of Chronic Obstructive Lung Diseases
Extracorporeal CO2 Removal for Acute Decompensation of COPD
Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome
ECCO2R as an Adjunct to NIV in AECOPD
ECCO2R in the Treatment of Acute Exacerbation of COPD With Severe Hypercapnia
Registry on the EXperience of Extracorporeal CO2 Removal in Intensive Care Units
Flow-flow ECCO2-R and 4 ml/kg Tidal Volume vs. 6 ml/kg Tidal Volume to Enhance Protection From VILI in Acute Lung Injury
All 7 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 7